Advertisement

Topics

VIVUS Announces Date of Second Quarter 2015 Update and Financial Results Conference Call

20:00 EDT 22 Jul 2015 | Globe Newswire

MOUNTAIN VIEW, Calif., July 23, 2015 (GLOBE NEWSWIRE) -- VIVUS, Inc. (NASDAQ:VVUS) today announced that it will provide an update and report financial results for the second quarter ended June 30, 2015 after the NASDAQ Market closes on Thursday, July 30, 2015. The company will conduct a conference call and an audio webcast at 4:30PM EDT the same day.

Date: July 30, 2015

Time: 4:30PM ET

Listen via Internet: http://ir.vivus.com/

Schedule this webcast into MS-Outlook calendar (click open when prompted): http://apps.shareholder.com/PNWOutlook/t.aspx?m=69243&k=50618D32

Toll-free: (877) 359-2916

International: (224) 357-2386

A webcast replay will be available on the VIVUS website for 30 days.

VIVUS is a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea and sexual health. For more information about the company, please visit www.vivus.com.

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely," "may," "plan," "potential," "predict," "opportunity" and "should," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. VIVUS does not undertake an obligation to update or revise any forward-looking statements. Investors should read the risk factors set forth in VIVUS's Form 10-K for the year ended December 31, 2014 as filed on February 25, 2015 and as amended by the Form 10-K/A filed on April 30, 2015, and periodic reports filed with the Securities and Exchange Commission.

CONTACT: VIVUS, Inc.
         Dana B. Shinbaum (Corporate Development & Investor Relations)
         650-934-5200
         shinbaum@vivus.com

         The Trout Group
         Brian Korb (Managing Director)
         646-378-2923
         bkorb@troutgroup.com

VIVUS logo

NEXT ARTICLE

More From BioPortfolio on "VIVUS Announces Date of Second Quarter 2015 Update and Financial Results Conference Call"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Endocrinology
Diabetes Diabetes Endocrine Obesity Oxycontin Renal Disease Thyroid Disorders Endocrinology is the study of the endocrine glands and the hormones that they secrete (Oxford Medical Dictionary). There are several groups of h...

Sleep Disorders
Sleep disorders disrupt sleep during the night, or cause sleepiness during the day, caused by physiological or psychological factors. The common ones include snoring and sleep apnea, insomnia, parasomnias, sleep paralysis, restless legs syndrome, circa...